BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount
Innovative drug developer ImmuneOnco (1541.HK) announced on Thursday that it plans to place 24.2 million new shares, representing about 5.61% of its enlarged share capital, to raise HK$351 million ($45…
ImmuneOnco banks on cutting-edge cancer drugs to attract IPO cash
The biopharma wants to use IPO proceeds to bring its cancer immunotherapies to market, having already built a lofty valuation with backers such as Eli Lilly Key Takeaways: ImmuneOnco’s main…
RELATED ARTICLES
-
BRIEF: Lancang Ancient Tea to raise $7.5 million via share placement at 16% discount
6911.HK -
BRIEF: WuXi XDC to raise $348 million via share placements at 4% discount
2268.HK
-
BRIEF: Guofu Hydrogen raises $11.67 million via share placement at 17% discount
2582.HK
-
BRIEF: Weimob raises $201 million through share placement at 8.9% discount
2013.HK
-
BRIEF: Lvji Tech to raise $19 million via rights issue at heavy discount
1745.HK
-
BRIEF: WuXi AppTec raises $975 Million through share placement at 6.9% discount
2359.HK 603259.SHG
-
BRIEF: Dmall raises $50 million in share placement at 10% discount
2586.HK
